Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serge Doan

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
The Ocular Surface|November 24, 2019
Neurotrophic keratitis: Frequency, etiologies, clinical management and outcomesSami Saad, Youssef Abdelmassih, Rana Saad, et al.
The British Journal of Ophthalmology|July 25, 2016
Management of severe and refractory Mooren's ulcers with rituximabDamien Guindolet, Clotilde Reynaud, Gaelle Clavel, et al.
The British Journal of Ophthalmology|May 16, 2019
Ocular involvement in epidermolysis bullosa acquisita with long-term follow-upAntoine Rousseau, Catherine Prost-Squarcioni, Serge Doan, et al.
Autoimmunity Reviews|April 12, 2022
Susac syndrome: A scoping reviewClémence David, Karim Sacré, Marie-Cécile Henri-Feugeas, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 15, 2018
Topical ocular 0.1% cyclosporine A cationic emulsion in dry eye disease patients with severe keratitis: experience through the French early-access programPierre-Jean Pisella, Marc Labetoulle, Serge Doan, et al.
Clinical Therapeutics|October 23, 2023
NOVATIVE: A Phase II/III, Multicenter, Double-masked, Randomized Study of Cyclosporine A 0.05% and 0.1% Ophthalmic Cationic Emulsion Versus Vehicle in Patients with Vernal KeratoconjunctivitisAndrea Leonardi, Pierre-Jean Pisella, José Manuel Benítez-Del-Castillo, et al.
Cornea|March 1, 2019
Therapeutic Challenges and Prognosis of Descemet's Membrane Endothelial Keratoplasty in Herpes Simplex Eye DiseaseYoussef Abdelmassih, Pierre Dubrulle, Charles Sitbon, et al.
Ophthalmology and Therapy|July 21, 2025
Continuous versus Intermittent Use of Tear Substitutes in Patients Treated with Anti-VEGF for Neovascular Age-Related Macular Degeneration: The TREDIA StudyHéloïse Torres-Villaros, Audrey Giocanti-Aurégan, Serge Doan, et al.
The American Journal of Pathology|July 23, 2011
EMMPRIN modulates epithelial barrier function through a MMP-mediated occludin cleavage: implications in dry eye diseaseEric Huet, Benoit Vallée, Jean Delbé, et al.
Medicine|April 17, 2007
Long-term outcome in Susac syndromeFleur Aubart-Cohen, Isabelle Klein, Jean-François Alexandra, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
The Ocular Surface|November 24, 2019
Neurotrophic keratitis: Frequency, etiologies, clinical management and outcomesSami Saad, Youssef Abdelmassih, Rana Saad, et al.
The British Journal of Ophthalmology|July 25, 2016
Management of severe and refractory Mooren's ulcers with rituximabDamien Guindolet, Clotilde Reynaud, Gaelle Clavel, et al.
The British Journal of Ophthalmology|May 16, 2019
Ocular involvement in epidermolysis bullosa acquisita with long-term follow-upAntoine Rousseau, Catherine Prost-Squarcioni, Serge Doan, et al.
Autoimmunity Reviews|April 12, 2022
Susac syndrome: A scoping reviewClémence David, Karim Sacré, Marie-Cécile Henri-Feugeas, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 15, 2018
Topical ocular 0.1% cyclosporine A cationic emulsion in dry eye disease patients with severe keratitis: experience through the French early-access programPierre-Jean Pisella, Marc Labetoulle, Serge Doan, et al.
Clinical Therapeutics|October 23, 2023
NOVATIVE: A Phase II/III, Multicenter, Double-masked, Randomized Study of Cyclosporine A 0.05% and 0.1% Ophthalmic Cationic Emulsion Versus Vehicle in Patients with Vernal KeratoconjunctivitisAndrea Leonardi, Pierre-Jean Pisella, José Manuel Benítez-Del-Castillo, et al.
Cornea|March 1, 2019
Therapeutic Challenges and Prognosis of Descemet's Membrane Endothelial Keratoplasty in Herpes Simplex Eye DiseaseYoussef Abdelmassih, Pierre Dubrulle, Charles Sitbon, et al.
Ophthalmology and Therapy|July 21, 2025
Continuous versus Intermittent Use of Tear Substitutes in Patients Treated with Anti-VEGF for Neovascular Age-Related Macular Degeneration: The TREDIA StudyHéloïse Torres-Villaros, Audrey Giocanti-Aurégan, Serge Doan, et al.
The American Journal of Pathology|July 23, 2011
EMMPRIN modulates epithelial barrier function through a MMP-mediated occludin cleavage: implications in dry eye diseaseEric Huet, Benoit Vallée, Jean Delbé, et al.
Medicine|April 17, 2007
Long-term outcome in Susac syndromeFleur Aubart-Cohen, Isabelle Klein, Jean-François Alexandra, et al.
Pageof 6